Table of Content

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17

2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.2 Major Growth Drivers 22
2.3 Market Restraints and Challenges 25
2.4 Emerging Opportunities and Market Trends 28
2.5 Porter’s Fiver Forces Analysis 32

3 Segmentation of Asia Pacific Market by Offering 36
3.1 Market Overview by Offering 36
3.2 Software 38
3.3 Service 39

4 Segmentation of Asia Pacific Market by Technology 40
4.1 Market Overview by Technology 40
4.2 Deep Learning 42
4.3 Supervised Learning 43
4.4 Reinforcement Learning 44
4.5 Unsupervised Learning 45
4.6 Other Technologies 46

5 Segmentation of Asia Pacific Market by Drug Type 47
5.1 Market Overview by Drug Type 47
5.2 Large-molecule Drugs 49
5.3 Small-molecular Drugs 50

6 Segmentation of Asia Pacific Market by Therapeutic Area 51
6.1 Market Overview by Therapeutic Area 51
6.2 Oncology 54
6.3 Neurodegenerative Diseases 55
6.4 Cardiovascular Disease 56
6.5 Metabolic Diseases 57
6.6 Other Therapeutic Areas 58

7 Segmentation of Asia Pacific Market by Application 59
7.1 Market Overview by Application 59
7.2 Information & Data Analysis 61
7.3 Drug Design 62
7.4 Drug Evaluation 63
7.5 Clinical Trials 64
7.6 Other Applications 65

8 Segmentation of Asia Pacific Market by End User 66
8.1 Market Overview by End User 66
8.2 Pharmaceutical & Biotechnology Companies 68
8.3 Academic & Research Institutes 69
8.4 Contract Research Organizations 70

9 Asia-Pacific Market 2019-2026 by Country 71
9.1 Overview of Asia-Pacific Market 71
9.2 China 74
9.3 Japan 76
9.4 India 79
9.5 Australia 81
9.6 South Korea 83
9.7 Rest of APAC Region 85

10 Competitive Landscape 87
10.1 Overview of Key Vendors 87
10.2 New Product Launch, Partnership, Investment, and M&A 92
10.3 Company Profiles 93
Atomwise, Inc. 93
BenevolentAI 95
Berg LLC 96
Bioage 97
BIOAGE 98
Cloud Pharmaceuticals, Inc. 99
Cyclica 100
Deep Genomics 101
Envisagenics 102
Exscientia 103
Google 104
IBM Corporation 105
Insilico Medicine 106
Microsoft Corporation 107
Numedii, Inc. 108
Numerate 109
NVIDIA Corporation 110
Owkin, Inc. 111
Twoxar, Incorporated 112
Verge Genomics 113
Xtalpi, Inc. 114

11 Investing in Asia Pacific Market: Risk Assessment and Management 115
11.1 Risk Evaluation of Asia Pacific Market 115
11.2 Critical Success Factors (CSFs) 118
Related Reports and Products 121



List of Figures


Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026 17
Figure 5. Asia Pacific AI in Drug Discovery Market, 2019-2026, $ mn 20
Figure 6. Primary Drivers and Impact Factors of Asia Pacific AI in Drug Discovery Market 22
Figure 7. Primary Restraints and Impact Factors of Asia Pacific AI in Drug Discovery Market 25
Figure 8. Investment Opportunity Analysis 29
Figure 9. Porter’s Fiver Forces Analysis of Asia Pacific AI in Drug Discovery Market 32
Figure 10. Breakdown of Asia Pacific AI in Drug Discovery Market by Offering, 2019-2026, % of Revenue 36
Figure 11. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Offering, Value ($ mn) and Share (%) 37
Figure 12. Asia Pacific AI in Drug Discovery Market: Software, 2015-2026, $ mn 38
Figure 13. Asia Pacific AI in Drug Discovery Market: Service, 2015-2026, $ mn 39
Figure 14. Breakdown of Asia Pacific AI in Drug Discovery Market by Technology, 2019-2026, % of Revenue 40
Figure 15. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Technology, Value ($ mn) and Share (%) 41
Figure 16. Asia Pacific AI in Drug Discovery Market: Deep Learning, 2015-2026, $ mn 42
Figure 17. Asia Pacific AI in Drug Discovery Market: Supervised Learning, 2015-2026, $ mn 43
Figure 18. Asia Pacific AI in Drug Discovery Market: Reinforcement Learning, 2015-2026, $ mn 44
Figure 19. Asia Pacific AI in Drug Discovery Market: Unsupervised Learning, 2015-2026, $ mn 45
Figure 20. Asia Pacific AI in Drug Discovery Market: Other Technologies, 2015-2026, $ mn 46
Figure 21. Breakdown of Asia Pacific AI in Drug Discovery Market by Drug Type, 2019-2026, % of Revenue 47
Figure 22. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Drug Type, Value ($ mn) and Share (%) 48
Figure 23. Asia Pacific AI in Drug Discovery Market: Large-molecule Drugs, 2015-2026, $ mn 49
Figure 24. Asia Pacific AI in Drug Discovery Market: Small-molecular Drugs, 2015-2026, $ mn 50
Figure 25. Breakdown of Asia Pacific AI in Drug Discovery Market by Therapeutic Area, 2019-2026, % of Revenue 51
Figure 26. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Therapeutic Area, Value ($ mn) and Share (%) 52
Figure 27. Asia Pacific AI in Drug Discovery Market: Oncology, 2015-2026, $ mn 54
Figure 28. Asia Pacific AI in Drug Discovery Market: Neurodegenerative Diseases, 2015-2026, $ mn 55
Figure 29. Asia Pacific AI in Drug Discovery Market: Cardiovascular Disease, 2015-2026, $ mn 56
Figure 30. Asia Pacific AI in Drug Discovery Market: Metabolic Diseases, 2015-2026, $ mn 57
Figure 31. Asia Pacific AI in Drug Discovery Market: Other Therapeutic Areas, 2015-2026, $ mn 58
Figure 32. Breakdown of Asia Pacific AI in Drug Discovery Market by Application, 2019-2026, % of Revenue 59
Figure 33. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by Application, Value ($ mn) and Share (%) 60
Figure 34. Asia Pacific AI in Drug Discovery Market: Information & Data Analysis, 2015-2026, $ mn 61
Figure 35. Asia Pacific AI in Drug Discovery Market: Drug Design, 2015-2026, $ mn 62
Figure 36. Asia Pacific AI in Drug Discovery Market: Drug Evaluation, 2015-2026, $ mn 63
Figure 37. Asia Pacific AI in Drug Discovery Market: Clinical Trials, 2015-2026, $ mn 64
Figure 38. Asia Pacific AI in Drug Discovery Market: Other Applications, 2015-2026, $ mn 65
Figure 39. Breakdown of Asia Pacific AI in Drug Discovery Market by End User, 2019-2026, % of Revenue 66
Figure 40. Contribution to Asia Pacific 2020-2026 Cumulative Revenue by End User, Value ($ mn) and Share (%) 67
Figure 41. Asia Pacific AI in Drug Discovery Market: Pharmaceutical & Biotechnology Companies, 2015-2026, $ mn 68
Figure 42. Asia Pacific AI in Drug Discovery Market: Academic & Research Institutes, 2015-2026, $ mn 69
Figure 43. Asia Pacific AI in Drug Discovery Market: Contract Research Organizations, 2015-2026, $ mn 70
Figure 44. Breakdown of APAC AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue 72
Figure 45. Contribution to APAC 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 73
Figure 46. AI in Drug Discovery Market in China, 2015-2026, $ mn 74
Figure 47. AI in Drug Discovery Market in Japan, 2015-2026, $ mn 77
Figure 48. AI in Drug Discovery Market in India, 2015-2026, $ mn 79
Figure 49. AI in Drug Discovery Market in Australia, 2015-2026, $ mn 81
Figure 50. AI in Drug Discovery Market in South Korea, 2015-2026, $ mn 83
Figure 51. AI in Drug Discovery Market in Rest of APAC, 2015-2026, $ mn 85
Figure 52. Growth Stage of Asia Pacific AI in Drug Discovery Industry over the Forecast Period 87
Figure 53. Share of Developments of Key Vendors by Strategy Type, 2015-2019 89


List of Tables


Table 1. Snapshot of Asia Pacific AI in Drug Discovery Market, 2019-2026 18
Table 2. Main Product Trends and Market Opportunities in Asia Pacific AI in Drug Discovery Market 28
Table 3. Asia Pacific AI in Drug Discovery Market by Offering, 2015-2026, $ mn 36
Table 4. Asia Pacific AI in Drug Discovery Market by Technology, 2015-2026, $ mn 40
Table 5. Asia Pacific AI in Drug Discovery Market by Drug Type, 2015-2026, $ mn 47
Table 6. Asia Pacific AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 51
Table 7. Selected Drug Development Pipelines Aided by AI 53
Table 8. Asia Pacific AI in Drug Discovery Market by Application, 2015-2026, $ mn 59
Table 9. Asia Pacific AI in Drug Discovery Market by End User, 2015-2026, $ mn 66
Table 10. APAC AI in Drug Discovery Market by Country, 2015-2026, $ mn 72
Table 11. China AI in Drug Discovery Market by Technology, 2015-2026, $ mn 75
Table 12. China AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 75
Table 13. China AI in Drug Discovery Market by End User, 2015-2026, $ mn 75
Table 14. Japan AI in Drug Discovery Market by Technology, 2015-2026, $ mn 78
Table 15. Japan AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 78
Table 16. Japan AI in Drug Discovery Market by End User, 2015-2026, $ mn 78
Table 17. India AI in Drug Discovery Market by Technology, 2015-2026, $ mn 80
Table 18. India AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 80
Table 19. India AI in Drug Discovery Market by End User, 2015-2026, $ mn 80
Table 20. Australia AI in Drug Discovery Market by Technology, 2015-2026, $ mn 82
Table 21. Australia AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 82
Table 22. Australia AI in Drug Discovery Market by End User, 2015-2026, $ mn 82
Table 23. South Korea AI in Drug Discovery Market by Technology, 2015-2026, $ mn 84
Table 24. South Korea AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn 84
Table 25. South Korea AI in Drug Discovery Market by End User, 2015-2026, $ mn 84
Table 26. AI in Drug Discovery Market in Rest of APAC by Country, 2015-2026, $ mn 86
Table 27. Use Cases of AI for Drug Discovery by Selected Pharmaceutical Companies 90
Table 28. Atomwise, Inc.: Company Snapshot 93
Table 29. Atomwise, Inc.: Business Segmentation 93
Table 30. Atomwise, Inc.: Product Portfolio 94
Table 31. Atomwise, Inc.: Revenue, 2016-2018, $ mn 94
Table 32. Atomwise, Inc.: Recent Developments 94
Table 33. Risk Evaluation for Investing in Asia Pacific Market, 2019-2026 116
Table 34. Critical Success Factors and Key Takeaways 119